Skip to main content
SpringerLink
Log in
Book cover

Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases pp 155–168Cite as

Gastrointestinal Involvement of Behçet’s Disease

  • Chapter
  • First Online:

  • 481 Accesses

Abstract

Behçet’s disease (BD) is a chronic inflammatory disease of unknown origin, featuring recurrent aphthous ulcers in the oral mucosa, uveitis, skin symptoms, and vulvar ulcers. Its inflammation can involve important organs such as the gastrointestinal tract, central nervous system, and vascular system. BD with gastrointestinal lesions is called intestinal BD, which is more common in Japan and Korea than elsewhere. Although ulcers at the ileocecal site are representative of intestinal BD, any part of the gastrointestinal tract can be involved. Therefore, the symptoms of intestinal BD are diverse and nonspecific. There are no specific markers for diagnosing this condition, and establishing the diagnosis of intestinal BD still remains a challenge. In the differential diagnosis of intestinal BD, Crohn’s disease and intestinal tuberculosis often need to be ruled out. Glucocorticoids and antitumor necrosis factor-α antibodies are the key agents for the treatment of intestinal BD. Many patients experience disease flare-up, and they sometimes follow a severe clinical course.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Skef W, Hamilton MJ, Arayssi T. Gastrointestinal Behcet’s disease: a review. World J Gastroenterol. 2015;21(13):3801–12.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Sakane T, Takeno M, Suzuki N, Inaba G. Behcet’s disease. N Engl J Med. 1999;341(17):1284–91.

    Article  CAS  PubMed  Google Scholar 

  3. Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54(3):213–20.

    Article  CAS  PubMed  Google Scholar 

  4. Alpsoy E. Behcet’s disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. 2016;43(6):620–32.

    Article  CAS  PubMed  Google Scholar 

  5. Takeuchi M, Kastner DL, Remmers EF. The immunogenetics of Behcet’s disease: a comprehensive review. J Autoimmun. 2015;64:137–48.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mahr A, Belarbi L, Wechsler B, et al. Population-based prevalence study of Behcet’s disease: differences by ethnic origin and low variation by age at immigration. Arthritis Rheum. 2008;58(12):3951–9.

    Article  PubMed  Google Scholar 

  7. Alpsoy E, Donmez L, Onder M, et al. Clinical features and natural course of Behcet’s disease in 661 cases: a multicentre study. Br J Dermatol. 2007;157(5):901–6.

    Article  CAS  PubMed  Google Scholar 

  8. Balta I, Akbay G, Kalkan G, Eksioglu M. Demographic and clinical features of 521 Turkish patients with Behcet’s disease. Int J Dermatol. 2014;53(5):564–9.

    Article  PubMed  Google Scholar 

  9. Ideguchi H, Suda A, Takeno M, Ueda A, Ohno S, Ishigatsubo Y. Behcet disease: evolution of clinical manifestations. Medicine (Baltimore). 2011;90(2):125–32.

    Article  Google Scholar 

  10. Gul A, Ohno S. HLA-B*51 and Behcet disease. Ocul Immunol Inflamm. 2012;20(1):37–43.

    Article  CAS  PubMed  Google Scholar 

  11. Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet’s disease susceptibility loci. Nat Genet. 2010;42(8):703–6.

    Article  CAS  PubMed  Google Scholar 

  12. Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet’s disease. Nat Genet. 2010;42(8):698–702.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kirino Y, Bertsias G, Ishigatsubo Y, et al. Genome-wide association analysis identifies new susceptibility loci for Behcet’s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013;45(2):202–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Tasliyurt T, Yigit S, Rustemoglu A, Gul U, Ates O. Common MEFV gene mutations in Turkish patients with Behcet’s disease. Gene. 2013;530(1):100–3.

    Article  CAS  PubMed  Google Scholar 

  15. Kirino Y, Zhou Q, Ishigatsubo Y, et al. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease. Proc Natl Acad Sci U S A. 2013;110(20):8134–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Zhou Q, Wang H, Schwartz DM, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016;48(1):67–73.

    Article  CAS  PubMed  Google Scholar 

  17. Akman A, Kacaroglu H, Donmez L, Bacanli A, Alpsoy E. Relationship between periodontal findings and Behcet’s disease: a controlled study. J Clin Periodontol. 2007;34(6):485–91.

    Article  PubMed  Google Scholar 

  18. Hirohata S, Oka H, Mizushima Y. Streptococcal-related antigens stimulate production of IL6 and interferon-gamma by T cells from patients with Behcet’s disease. Cell Immunol. 1992;140(2):410–9.

    Article  CAS  PubMed  Google Scholar 

  19. Neves FS, Spiller F. Possible mechanisms of neutrophil activation in Behcet’s disease. Int Immunopharmacol. 2013;17(4):1206–10.

    Article  CAS  PubMed  Google Scholar 

  20. Hamzaoui K, Hamzaoui A, Hentati F, et al. Phenotype and functional profile of T cells expressing gamma delta receptor from patients with active Behcet’s disease. J Rheumatol. 1994;21(12):2301–6.

    CAS  PubMed  Google Scholar 

  21. Leng RX, Chen GM, Pan HF, Ye DQ. The role of IL-23/IL-17 axis in the etiopathogenesis of Behcet’s disease. Clin Rheumatol. 2010;29(10):1209.

    Article  PubMed  Google Scholar 

  22. Ben Ahmed M, Houman H, Miled M, Dellagi K, Louzir H. Involvement of chemokines and Th1 cytokines in the pathogenesis of mucocutaneous lesions of Behcet’s disease. Arthritis Rheum. 2004;50(7):2291–5.

    Article  CAS  PubMed  Google Scholar 

  23. Grigg EL, Kane S, Katz S. Mimicry and deception in inflammatory bowel disease and intestinal Behcet disease. Gastroenterol Hepatol (N Y). 2012;8(2):103–12.

    Google Scholar 

  24. Bayraktar Y, Ozaslan E, Van Thiel DH. Gastrointestinal manifestations of Behcet’s disease. J Clin Gastroenterol. 2000;30(2):144–54.

    Article  CAS  PubMed  Google Scholar 

  25. Yi SW, Cheon JH, Kim JH, et al. The prevalence and clinical characteristics of esophageal involvement in patients with Behcet’s disease: a single center experience in Korea. J Korean Med Sci. 2009;24(1):52–6.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Houman MH, Ben Ghorbel I, Lamloum M, et al. Esophageal involvement in Behcet’s disease. Yonsei Med J. 2002;43(4):457–60.

    Article  PubMed  Google Scholar 

  27. Oose T, Tokutomi K, Takeuchi A, Hashimoto T. [A case of Behcet’s disease with severe esophageal stenosis treated with esophageal bujie]. Ryumachi. 1995;35(1):81–4.

    Google Scholar 

  28. Morimoto Y, Tanaka Y, Itoh T, Yamamoto S, Kurihara Y, Nishikawa K. Esophagobronchial fistula in a patient with Behcet’s disease: report of a case. Surg Today. 2005;35(8):671–6.

    Article  PubMed  Google Scholar 

  29. Powderly WG, Lombard MG, Murray FE, O’Connell D, Counihan TB, Lennon JR. Oesophageal ulceration in Behcet’s disease presenting with haemorrhage. Ir J Med Sci. 1987;156(6):193–4.

    Article  CAS  PubMed  Google Scholar 

  30. Bektas M, Altan M, Alkan M, Ormeci N, Soykan I. Manometric evaluation of the esophagus in patients with Behcet’s disease. Digestion. 2007;76(3–4):192–5.

    Article  PubMed  Google Scholar 

  31. Ning-Sheng L, Ruay-Sheng L, Kuo-Chih T. High frequency of unusual gastric/duodenal ulcers in patients with Behcet’s disease in Taiwan: a possible correlation of MHC molecules with the development of gastric/duodenal ulcers. Clin Rheumatol. 2005;24(5):516–20.

    Article  PubMed  Google Scholar 

  32. Arendt T, Kloehn S, Bastian A, et al. A case of Behcet’s syndrome presenting with Dieulafoy’s ulcer. Z Gastroenterol. 1997;35(10):935–8.

    CAS  PubMed  Google Scholar 

  33. Abe T, Yachi A, Yabana T, et al. Gastric non-Hodgkin’s lymphoma associated with Behcet’s disease. Intern Med. 1993;32(8):663–7.

    Article  CAS  PubMed  Google Scholar 

  34. Ozenc A, Bayraktar Y, Baykal A. Pyloric stenosis with esophageal involvement in Behcet’s syndrome. Am J Gastroenterol. 1990;85(6):727–8.

    CAS  PubMed  Google Scholar 

  35. Behcet BR. Disease associated with severe gastroparesis: a dramatic response to combination therapy with methotrexate and infliximab. Arthritis Rheum. 2001;44(9 Suppl):S40–520.

    Google Scholar 

  36. Avci O, Ellidokuz E, Simsek I, Buyukgebiz B, Gunes AT. Helicobacter pylori and Behcet’s disease. Dermatology. 1999;199(2):140–3.

    Article  CAS  PubMed  Google Scholar 

  37. Hamdulay SS, Cheent K, Ghosh C, Stocks J, Ghosh S, Haskard DO. Wireless capsule endoscopy in the investigation of intestinal Behcet’s syndrome. Rheumatology (Oxford). 2008;47(8):1231–4.

    Article  CAS  Google Scholar 

  38. Neves FS, Fylyk SN, Lage LV, et al. Behcet’s disease: clinical value of the video capsule endoscopy for small intestine examination. Rheumatol Int. 2009;29(5):601–3.

    Article  PubMed  Google Scholar 

  39. Lee CR, Kim WH, Cho YS, et al. Colonoscopic findings in intestinal Behcet’s disease. Inflamm Bowel Dis. 2001;7(3):243–9.

    Article  CAS  PubMed  Google Scholar 

  40. Le Thi Huong D, Wechsler B, Dell’Isola B, et al. Acute pancreatitis in Behcet’s disease. Dig Dis Sci. 1992;37(9):1452–3.

    Article  PubMed  Google Scholar 

  41. Backmund M, Schomerus P. Acute pancreatitis and pericardial effusion in Behcet’s disease. Gastroenterology. 1999;117(1):286.

    Article  CAS  PubMed  Google Scholar 

  42. Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behcet’s syndrome: a review of Japanese autopsy registry data. Hum Pathol. 1985;16(8):790–5.

    Article  CAS  PubMed  Google Scholar 

  43. Chawla S, Atten MJ, Attar BM. Acute pancreatitis as a rare initial manifestation of Wegener’s granulomatosis. A case based review of literature. JOP. 2011;12(2):167–9.

    PubMed  Google Scholar 

  44. Kuniyoshi Y, Koja K, Miyagi K, et al. Surgical treatment of Budd-Chiari syndrome induced by Behcet’s disease. Ann Thorac Cardiovasc Surg. 2002;8(6):374–80.

    PubMed  Google Scholar 

  45. Ben Ghorbel I, Ennaifer R, Lamloum M, Khanfir M, Miled M, Houman MH. Budd-Chiari syndrome associated with Behcet’s disease. Gastroenterol Clin Biol. 2008;32(3):316–20.

    Article  CAS  PubMed  Google Scholar 

  46. Bayraktar Y, Balkanci F, Bayraktar M, Calguneri M. Budd-Chiari syndrome: a common complication of Behcet’s disease. Am J Gastroenterol. 1997;92(5):858–62.

    CAS  PubMed  Google Scholar 

  47. Korkmaz C, Kasifoglu T, Kebapci M. Budd-Chiari syndrome in the course of Behcet’s disease: clinical and laboratory analysis of four cases. Joint Bone Spine. 2007;74(3):245–8.

    Article  PubMed  Google Scholar 

  48. Calamia KT, Schirmer M, Melikoglu M. Major vessel involvement in Behcet’s disease: an update. Curr Opin Rheumatol. 2011;23(1):24–31.

    Article  PubMed  Google Scholar 

  49. Manna R, Ghirlanda G, Bochicchio GB, et al. Chronic active hepatitis and Behcet’s syndrome. Clin Rheumatol. 1985;4(1):93–6.

    Article  CAS  PubMed  Google Scholar 

  50. Orloff LA, Orloff MJ. Budd-Chiari syndrome caused by Behcet’s disease: treatment by side-to-side portacaval shunt. J Am Coll Surg. 1999;188(4):396–407.

    Article  CAS  PubMed  Google Scholar 

  51. Sato S, Yashiro M, Matsuoka N, et al. Behcet disease associated with gastrointestinal amyloidosis manifested as hematochezia: a case report. Medicine (Baltimore). 2018;97(26):e11153.

    Article  Google Scholar 

  52. Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet. 1990;335(8697):1078–80.

    Google Scholar 

  53. International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD). The International Criteria for Behcet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol. 2014;28(3):338–47.

    Article  Google Scholar 

  54. Mizushima Y. Recent research into Behcet’s disease in Japan. Int J Tissue React. 1988;10(2):59–65.

    CAS  PubMed  Google Scholar 

  55. Cheon JH, Kim ES, Shin SJ, et al. Development and validation of novel diagnostic criteria for intestinal Behcet’s disease in Korean patients with ileocolonic ulcers. Am J Gastroenterol. 2009;104(10):2492–9.

    Article  PubMed  Google Scholar 

  56. Lee SK, Kim BK, Kim TI, Kim WH. Differential diagnosis of intestinal Behcet’s disease and Crohn’s disease by colonoscopic findings. Endoscopy. 2009;41(1):9–16.

    Article  CAS  PubMed  Google Scholar 

  57. Ng SC, Hirai HW, Tsoi KK, et al. Systematic review with meta-analysis: accuracy of interferon-gamma releasing assay and anti-Saccharomyces cerevisiae antibody in differentiating intestinal tuberculosis from Crohn’s disease in Asians. J Gastroenterol Hepatol. 2014;29(9):1664–70.

    Article  PubMed  Google Scholar 

  58. Cheon JH, Kim WH. An update on the diagnosis, treatment, and prognosis of intestinal Behcet’s disease. Curr Opin Rheumatol. 2015;27(1):24–31.

    Article  CAS  PubMed  Google Scholar 

  59. Jung YS, Cheon JH, Park SJ, Hong SP, Kim TI, Kim WH. Long-term clinical outcomes of Crohn’s disease and intestinal Behcet’s disease. Inflamm Bowel Dis. 2013;19(1):99–105.

    Article  PubMed  Google Scholar 

  60. Yazisiz V. Similarities and differences between Behcet’s disease and Crohn’s disease. World J Gastrointest Pathophysiol. 2014;5(3):228–38.

    Article  PubMed  PubMed Central  Google Scholar 

  61. Papp M, Norman GL, Altorjay I, Lakatos PL. Utility of serological markers in inflammatory bowel diseases: gadget or magic? World J Gastroenterol. 2007;13(14):2028–36.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Hatemi G, Silman A, Bang D, et al. Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease. Ann Rheum Dis. 2009;68(10):1528–34.

    Article  CAS  PubMed  Google Scholar 

  63. Cheon JC, Celik AF, Kim WH. Behçet’s disease: gastrointestinal involvement. In: Yazici Y, Yazici H, editors. Behçet’s syndrome. 1st ed. New York: Springer; 2010. p. 165–88.

    Chapter  Google Scholar 

  64. Hisamatsu T, Ueno F, Matsumoto T, et al. The 2nd edition of consensus statements for the diagnosis and management of intestinal Behcet’s disease: indication of anti-TNFalpha monoclonal antibodies. J Gastroenterol. 2014;49(1):156–62.

    Article  CAS  PubMed  Google Scholar 

  65. Saleh Z, Arayssi T. Update on the therapy of Behcet disease. Ther Adv Chronic Dis. 2014;5(3):112–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  66. Travis SP, Czajkowski M, McGovern DP, Watson RG, Bell AL. Treatment of intestinal Behcet’s syndrome with chimeric tumour necrosis factor alpha antibody. Gut. 2001;49(5):725–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Hassard PV, Binder SW, Nelson V, Vasiliauskas EA. Anti-tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behcet’s disease: a case report. Gastroenterology. 2001;120(4):995–9.

    Article  CAS  PubMed  Google Scholar 

  68. Kinoshita H, Kunisaki R, Yamamoto H, et al. Efficacy of infliximab in patients with intestinal Behcet’s disease refractory to conventional medication. Intern Med. 2013;52(17):1855–62.

    Article  PubMed  CAS  Google Scholar 

  69. Bawazeer A, Raffa LH, Nizamuddin SH. Clinical experience with adalimumab in the treatment of ocular Behcet disease. Ocul Immunol Inflamm. 2010;18(3):226–32.

    Article  CAS  PubMed  Google Scholar 

  70. Tanida S, Inoue N, Kobayashi K, et al. Adalimumab for the treatment of Japanese patients with intestinal Behcet’s disease. Clin Gastroenterol Hepatol. 2015;13(5):940–948.e943.

    Article  CAS  PubMed  Google Scholar 

  71. Ariyachaipanich A, Berkelhammer C, Nicola H. Intestinal Behcet’s disease: maintenance of remission with adalimumab monotherapy. Inflamm Bowel Dis. 2009;15(12):1769–71.

    Article  PubMed  Google Scholar 

  72. Jung YS, Yoon JY, Lee JH, et al. Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease. Inflamm Bowel Dis. 2011;17(7):1594–602.

    Article  PubMed  Google Scholar 

  73. Jung YS, Yoon JY, Hong SP, Kim TI, Kim WH, Cheon JH. Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet’s disease. Inflamm Bowel Dis. 2012;18(6):1064–71.

    Article  PubMed  Google Scholar 

  74. Park JJ, Kim WH, Cheon JH. Outcome predictors for intestinal Behcet’s disease. Yonsei Med J. 2013;54(5):1084–90.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Saadoun D, Wechsler B, Desseaux K, et al. Mortality in Behcet’s disease. Arthritis Rheum. 2010;62(9):2806–12.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan

    Tomoyuki Asano, Shuzo Sato & Kiyoshi Migita

Authors
  1. Tomoyuki Asano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shuzo Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kiyoshi Migita
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomoyuki Asano .

Editor information

Editors and Affiliations

  1. Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan

    Hiromasa Ohira

  2. Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan

    Kiyoshi Migita

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Asano, T., Sato, S., Migita, K. (2019). Gastrointestinal Involvement of Behçet’s Disease. In: Ohira, H., Migita, K. (eds) Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-13-6524-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-6524-9_10

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-6523-2

  • Online ISBN: 978-981-13-6524-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation